Robert E. Lee TROUT
25Patents
10h-index
17Co-inventors
68Inventor score
Filing activity: Dec 18, 2007 → May 1, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9511142B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 46 | Active |
| US8912169B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 30 | Active |
| US9040504B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 28 | Active |
| US9403850B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 22 | Active |
| US9376454B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9422314B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 21 | Active |
| US9637504B2 | Beta-lactamase inhibitors | Human Necessities | 17 | Active |
| US9828391B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US9771382B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 13 | Active |
| US9783555B2 | Beta-lactamase inhibitors | Human Necessities | 12 | Active |
| US9926336B2 | Beta-lactamase inhibitors | Human Necessities | 9 | Active |
| US9802966B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 9 | Active |
| US9944658B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 9 | Active |
| US10214547B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 8 | Active |
| US10125152B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 7 | Active |
| US10669290B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 6 | Active |
| US10294248B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 6 | Active |
| US10294247B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 5 | Active |
| US10464952B2 | Beta-lactamase inhibitors | Human Necessities | 4 | Active |
| US11008346B2 | Beta-lactamase inhibitors | Human Necessities | 0 | Active |
| US11414435B2 | Beta-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US11332485B2 | Penicillin-binding protein inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12173018B2 | Penicillin-binding protein inhibitors | Human Necessities | 0 | Active |
| US10093685B2 | Beta-lactamase inhibitors | General | 0 | Revoked |
| US7902394B2 | Calcilytic compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.